Epiliquid Holding, Inc

This study is testing a new blood test called Delta-HLD to see how well it can detect colorectal cancer in average-risk people aged 45-75. About 3,200 participants will give a blood sample before their scheduled screening colonoscopy, which will be used as the gold standard for c…

This study is testing a new blood test called delta-HLD to see if it can accurately detect liver cancer (hepatocellular carcinoma). Researchers will compare blood and tissue samples from 200 people, half with liver cancer and half with liver cirrhosis but no cancer. If the test w…